---
date created: 2024-11-16
dg-publish: true
tags:
  - meds
---
**Class:**
- Atypical Antipsychotic

**Mechanism of Action (MOA):**
- Partial agonist at dopamine D2 and serotonin 5-HT1A receptors and antagonist at serotonin 5-HT2A receptors.

**Indications/Uses:**
- Schizophrenia
- Bipolar disorder (manic and mixed episodes)
- Major Depressive Disorder (MDD) as adjunct therapy
- Irritability associated with autistic disorder

**Side Effects:**
- Insomnia
- Anxiety
- Nausea
- Dizziness
- Weight gain (less common compared to other atypical antipsychotics)

**Adverse Effects:**
- Extrapyramidal symptoms (EPS)
- Tardive dyskinesia
- Neuroleptic malignant syndrome (NMS)
- Suicidal thoughts (in young adults and adolescents)

**Nursing Teaching and Implications:**
- Monitor for signs of EPS and NMS.
- Educate about potential activation effects like insomnia.
- Discuss the importance of not abruptly discontinuing the medication.

**Contraindications:**
- Known hypersensitivity to aripiprazole